Subjects must be diagnosed with Stage III or Stage IV ovarian carcinoma (which includes primary peritoneal carcinoma or fallopian rube carcinoma)

All subjects must be enrolled within 90 days of diagnosis

No prior treatment for ovarian carcinoma

All subjects have agreed to a treatment plan of neoadjuvant chemotherapy and subsequent planned interval debulking surgery with an MSKCC surgeon

Participants must be initiating treatment at Gynecologic Medical Oncology clinics at MSKCC Manhattan

Proficiency in English in the determination of the investigators of by patient self-report

Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy